62370-80-3 Usage
Molecular structure
A complex structure consisting of a benzyl group, a piperidine ring, an isoquinoline moiety, and a benzoate group.
Benzyl group
A phenyl group attached to a methyl group (C6H5-CH2-).
Piperidine ring
A six-membered nitrogen-containing heterocyclic ring (C5H10N).
Isoquinoline moiety
A tricyclic aromatic compound consisting of two fused benzene rings and one additional nitrogen atom (C9H7N).
Benzoate group
A functional group derived from benzoic acid (C6H5COO-).
Medicinal chemistry applications
Potential use in the development of pharmaceutical drugs.
Organic synthesis and chemical research
Possible applications in organic synthesis and chemical research due to its unique and intricate structure.
Further research and testing
Necessary to fully understand the properties and potential uses of 1-benzyl-4-(isoquinolin-1-yl)piperidin-4-yl benzoate.
Check Digit Verification of cas no
The CAS Registry Mumber 62370-80-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,2,3,7 and 0 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 62370-80:
(7*6)+(6*2)+(5*3)+(4*7)+(3*0)+(2*8)+(1*0)=113
113 % 10 = 3
So 62370-80-3 is a valid CAS Registry Number.
62370-80-3Relevant academic research and scientific papers
Isoquinolines and anti-depressants containing them
-
, (2008/06/13)
Isoquinolines of the formula STR1 wherein R1 is H or alkyl of 1 - 4 carbon atoms, R2 is H and R3 is OH or R2 and R3 collectively are a C--C bond, and physiologically acceptable acid addition salts thereof have anti-depressant activity and can be prepared by solvolyzing or hydrogenolyzing a compound of the formula STR2 or an acid addition salt thereof, wherein R4 is R1 or R6, R5 is OR7 or, when R4 is R6, R3 ; R6 and R7 are radicals which can be split off solvolytically or hydrogenolytically and R1 and R2 are as above; and the optional step of dehydrating a resulting carbinol (R2 is H, R3 is OH) and/or treating a resulting compound (R1 is H) with a N-alkylating agent and/or converting a resulting base to a physiologically acceptable acid addition salt by treatment with and acid.
